Statistical analysis methods for QT/QTc prolongation

被引:4
|
作者
Ma, Haijun [1 ]
Smith, Brian [1 ]
Dmitrienko, Alex
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
cardiac repolarization; QTc correction; QTc interval; QT prolongation; thorough QT/QTc study;
D O I
10.1080/10543400801995494
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prolonged QT interval is associated with life-threatening arrhythmias. Regulatory authorities have paid special attention to investigating the drug-induced delay of cardiac repolarization. Studies aimed at evaluating QT prolongation have become a routine part of safety packages across the pharmaceutical industry. However, the assessment of QT interval prolongation on the surface electrocardiogram is complicated by the fact that many factors influence the duration of the QT interval, among which heart rate plays a predominant role. Some widely used corrections of the QT interval for varying heart rate are known to be inadequate. Many alternatives have been proposed in the literature. Using information obtained from Eli Lilly thorough QT studies, we examine the performance of several approaches to the analysis of QT changes, including subject-specific (individual) QT corrections and model-based QT analysis methods. The simulation results indicate that the mixed-effects modeling approach proposed in this paper is more powerful than the other methods, all of which are commonly used in QT studies.
引用
收藏
页码:553 / 563
页数:11
相关论文
共 50 条
  • [22] Absence of QTc Prolongation with Buprenorphine/Samidorphan Combination: A Thorough QT/QTc (tQT) Study in Healthy Volunteers
    Lu, Hong
    Hard, Marjie
    Kleiman, Robert
    Liu, Wenlei
    Bergsma, Tim
    Stanford, Arielle D.
    Nangia, Narinder
    von Moltke, Lisa
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S141 - S142
  • [23] Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
    Piotrovsky, V
    AAPS JOURNAL, 2005, 7 (03): : E609 - E624
  • [24] Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team
    Scott D. Patterson
    Drug information journal : DIJ / Drug Information Association, 2005, 39 (3): : 243 - 265
  • [25] Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
    Vladimir Piotrovsky
    The AAPS Journal, 7
  • [26] Investigating drug-induced QT and QTc prolongation in the clinic: A review of statistical design and analysis considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team
    Patterson, S
    Agin, M
    Anziono, R
    Burgess, T
    Chuang-Stein, C
    Dmitrienko, A
    Ferber, G
    Geraldes, M
    Ghosh, K
    Menton, R
    Natarajan, J
    Offen, W
    Sound, J
    Smith, B
    Suresh, R
    Zariffa, N
    DRUG INFORMATION JOURNAL, 2005, 39 (03): : 243 - 265
  • [27] CONFIRMATION OF QT PROLONGATION BY ORAL MOXIFLOXACIN IN HEALTHY JAPANESE SUBJECTS FOR THOROUGH QT/QTC STUDIES IN JAPAN
    Kumagai, Y.
    Ikeda, Y.
    Fujita, T.
    Sahashi, K.
    Saikawa, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 102 - 102
  • [28] A Polygenic Predictor of Baseline QTc is Associated With Sotalol-Induced QT Prolongation
    Lancaster, Megan C.
    Davogustto, Giovanni
    Prifti, Edi
    Perret, Claire
    Funck-Brentano, Christian
    Roden, Dan M.
    Salem, Joe-Elie
    CIRCULATION, 2024, 150 (24) : 1984 - 1986
  • [29] Evaluation of the potential for QT/QTc interval prolongation for therapeutic biotechnology products.
    Schrieber, Sarah J.
    Zhao, Hong
    Keegan, Patricia
    Booth, Brian
    Rahman, Nam Atiqur
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Risk of QT/QTc Prolongation Among Newer Non-SSRI Antidepressants
    Jasiak, Natalia M.
    Bostwick, Jolene R.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (12) : 1620 - 1628